Biotricity (BTCY)
(Delayed Data from OTC)
$0.39 USD
-0.04 (-9.30%)
Updated Aug 26, 2024 03:59 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Cash flow Statements
Fiscal Year End for Biotricity Inc falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -14.09 | -18.66 | -29.13 | -15.49 | -11.07 |
Depreciation/Amortization & Depletion | 2.18 | 0.75 | 9.29 | 2.48 | 0.09 |
Net Change from Assets/Liabilities | 3.68 | 2.31 | -0.12 | -0.63 | -0.29 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.54 | 2.05 | 4.80 | 2.56 | 3.40 |
Net Cash From Operating Activities | -6.69 | -13.55 | -15.16 | -11.08 | -7.86 |
Property & Equipment | 0.00 | 0.00 | -0.03 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | -0.03 | 0.00 | 0.00 |
Uses of Funds
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.94 | -0.88 | 15.54 | 0.27 | 7.86 |
Issuance (Repayment) of Debt | 2.96 | 2.36 | 12.26 | 12.95 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.85 | 1.48 | -1.66 | -0.41 | 1.20 |
Payment of Dividends & Other Distributions | -0.02 | -0.95 | -0.97 | -0.60 | -0.18 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 6.74 | 2.00 | 25.17 | 12.20 | 8.88 |
Effect of Exchange Rate Changes | 0.17 | 0.05 | -0.11 | 0.13 | -0.13 |
Net Change In Cash & Equivalents | 0.22 | -11.50 | 9.87 | 1.19 | 1.02 |
Cash at Beginning of Period | 0.57 | 12.07 | 2.20 | 0.95 | 0.06 |
Cash at End of Period | 0.79 | 0.57 | 12.07 | 2.20 | 0.95 |
Diluted Net EPS | -1.66 | -2.26 | -3.99 | -2.63 | -1.89 |
Fiscal Year End for Biotricity Inc falls in the month of March.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -3.69 | -14.09 | -9.91 | -7.10 | -3.41 |
Depreciation/Amortization & Depletion | 1.15 | 2.18 | 1.58 | 1.16 | 0.56 |
Net Change from Assets/Liabilities | 0.15 | 3.68 | 1.65 | 1.21 | 0.83 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.90 | 1.54 | 1.15 | 0.52 | 0.19 |
Net Cash From Operating Activities | -1.49 | -6.69 | -5.53 | -4.22 | -1.83 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.44 | 2.94 | 2.02 | 2.02 | 0.00 |
Issuance (Repayment) of Debt | 0.28 | 2.96 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.84 | 0.85 | 2.95 | 2.75 | 1.34 |
Payment of Dividends & Other Distributions | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.87 | 6.74 | 4.95 | 4.76 | 1.33 |
Effect of Exchange Rate Changes | -0.06 | 0.17 | 0.09 | 0.09 | -0.02 |
Net Change In Cash & Equivalents | -0.69 | 0.22 | -0.49 | 0.63 | -0.52 |
Cash at Beginning of Period | 0.79 | 0.57 | 0.57 | 0.57 | 0.57 |
Cash at End of Period | 0.10 | 0.79 | 0.09 | 1.20 | 0.05 |
Diluted Net EPS | -0.49 | -0.81 | -0.34 | -0.44 | -0.07 |